Abstract
The authors carried out a double blind therapeutic trial with neuramide in 20 drug addicts affected by acute type B anti-delta negative viral hepatitis. The H/S ratio together with the most important clinical and hepatological parameters seem to improve following treatment.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
-
English Abstract
MeSH terms
-
Adolescent
-
Adult
-
Antibodies, Monoclonal / immunology
-
Antimicrobial Cationic Peptides*
-
Clinical Trials as Topic
-
Double-Blind Method
-
Female
-
Hepatitis B / drug therapy*
-
Hepatitis B Antibodies / analysis
-
Hepatitis B Surface Antigens / analysis
-
Hepatitis B e Antigens / analysis
-
Humans
-
Immunoglobulin M / analysis
-
Killer Cells, Natural / immunology
-
Male
-
Peptides / therapeutic use*
-
Placebos
-
Substance-Related Disorders
-
T-Lymphocytes, Helper-Inducer / immunology
-
T-Lymphocytes, Regulatory / immunology
Substances
-
Antibodies, Monoclonal
-
Antimicrobial Cationic Peptides
-
Hepatitis B Antibodies
-
Hepatitis B Surface Antigens
-
Hepatitis B e Antigens
-
Immunoglobulin M
-
Peptides
-
Placebos
-
neuramide